Clinical Trial Update: Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating gum arabic as an immunomodulator for rheumatoid arthritis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Gum Arabic (arabic gum)

Snippet

Sponsor: Lamis Kaddam | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN